First Light Asset Management’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.5M Buy
2,861,167
+401,201
+16% +$6.46M 2.76% 15
2026
Q1
$32.3M Buy
2,459,966
+1,110,484
+82% +$16.7M 2.9% 11
2025
Q4
$20.8M Sell
1,349,482
-10,589
-0.8% -$142K 1.59% 26
2025
Q3
$14M Sell
1,360,071
-20,339
-1% -$192K 1.32% 28
2025
Q2
$15.4M Sell
1,380,410
-203,638
-13% -$2.55M 1.99% 19
2025
Q1
$19.5M Buy
+1,584,048
New +$19.8M 2.22% 17

Other funds holding NPCE

First Light Asset Management's NPCE Position: Q2 2026 in Review

First Light Asset Management increased its Neuropace (NPCE) stake by 16% in Q2 2026, buying an estimated $6.46M and bringing the position to 2,861,167 shares worth $45.5M. The position accounts for 2.76% of the portfolio, ranked #15.

First Light Asset Management first reported a position in NPCE in Q1 2025 and has held it in 6 quarters since. 112 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • First Light Asset Management held 2,861,167 shares of Neuropace worth $45.5M as of Q2 2026.
  • First Light Asset Management bought 401,201 Neuropace shares in Q2 2026, an estimated $6.46M.
  • Neuropace made up 2.76% of First Light Asset Management's portfolio in Q2 2026, its #15 holding.
  • First Light Asset Management first reported a position in Neuropace in Q1 2025 and has held it in 6 quarters since.
  • 112 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on First Light Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.